Related references
Note: Only part of the references are listed.Individualized atrophy scores predict dementia onset in familial frontotemporal lobar degeneration
Adam M. Staffaroni et al.
ALZHEIMERS & DEMENTIA (2020)
The longitudinal evaluation of familial frontotemporal dementia subjects protocol: Framework and methodology
Bradley Boeve et al.
ALZHEIMERS & DEMENTIA (2020)
Genetic screening of a large series of North American sporadic and familial frontotemporal dementia cases
Eliana Marisa Ramos et al.
ALZHEIMERS & DEMENTIA (2020)
Utility of the global CDR® plus NACC FTLD rating and development of scoring rules: Data from the ARTFL/LEFFTDS Consortium
Toji Miyagawa et al.
ALZHEIMERS & DEMENTIA (2020)
Comparison of sporadic and familial behavioral variant frontotemporal dementia (FTD) in a North American cohort
Hilary W. Heuer et al.
ALZHEIMERS & DEMENTIA (2020)
Plasma glial fibrillary acidic protein is raised in progranulin-associated frontotemporal dementia
Carolin Heller et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2020)
Diagnostic value of plasma phosphorylated tau181 in Alzheimer's disease and frontotemporal lobar degeneration
Elisabeth H. Thijssen et al.
NATURE MEDICINE (2020)
Serum neurofilament light chain in genetic frontotemporal dementia: a longitudinal, multicentre cohort study (vol 18, pg 1103, 2019)
E. L. van der Ende et al.
LANCET NEUROLOGY (2020)
Therapeutic trial design for frontotemporal dementia and related disorders
Philippe Desmarais et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2019)
Neurofilaments and tau in CSF in an infant with SMA type 1 treated with nusinersen
Benedikt Winter et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2019)
Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer's disease
Oliver Preische et al.
NATURE MEDICINE (2019)
Serum neurofilament light chain in genetic frontotemporal dementia: a longitudinal, multicentre cohort study
Emma L. van der Ende et al.
LANCET NEUROLOGY (2019)
Potential genetic modifiers of disease risk and age at onset in patients with frontotemporal lobar degeneration and GRN mutations: a genome-wide association study
Cyril Pottier et al.
LANCET NEUROLOGY (2018)
Biomarkers for Alzheimer's disease: current status and prospects for the future
K. Blennow et al.
JOURNAL OF INTERNAL MEDICINE (2018)
Cerebrospinal fluid biomarkers predict frontotemporal dementia trajectory
Peter A. Ljubenkov et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2018)
The effects of behavioral and psychological symptoms on caregiver burden in frontotemporal dementia, Lewy body dementia, and Alzheimer's disease: clinical experience in China
Shuling Liu et al.
AGING & MENTAL HEALTH (2017)
Report From the NEI/FDA Endpoints Workshop on Age-Related Macular Degeneration and Inherited Retinal Diseases
Karl Csaky et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2017)
Shared genetic risk between corticobasal degeneration, progressive supranuclear palsy, and frontotemporal dementia
Jennifer S. Yokoyama et al.
ACTA NEUROPATHOLOGICA (2017)
Genetics of Frontotemporal Dementia
Diana A. Olszewska et al.
CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS (2016)
Serum neurofilament light chain protein is a measure of disease intensity in frontotemporal dementia
Jonathan D. Rohrer et al.
NEUROLOGY (2016)
Neurofilament Light Chain in Blood and CSF as Marker of Disease Progression in Mouse Models and in Neurodegenerative Diseases
Mehtap Bacioglu et al.
NEURON (2016)
Plasma neurofilament light chain predicts progression in progressive supranuclear palsy
Julio C. Rojas et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2016)
Neurofilament light chain: a biomarker for genetic frontotemporal dementia
Lieke H. Meeter et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2016)
Presymptomatic cognitive and neuroanatomical changes in genetic frontotemporal dementia in the Genetic Frontotemporal dementia Initiative (GENFI) study: a cross-sectional analysis
Jonathan D. Rohrer et al.
LANCET NEUROLOGY (2015)
Neurofilament light chain A prognostic biomarker in amyotrophic lateral sclerosis
Ching-Hua Lu et al.
NEUROLOGY (2015)
Cerebrospinal Fluid Neurofilament Concentration Reflects Disease Severity in Frontotemporal Degeneration
Carole S. Scherling et al.
ANNALS OF NEUROLOGY (2014)
Axonal Damage in Relapsing Multiple Sclerosis is Markedly Reduced by Natalizumab
Martin Gunnarsson et al.
ANNALS OF NEUROLOGY (2011)
Identification of common variants influencing risk of the tauopathy progressive supranuclear palsy
Guenter U. Hoeglinger et al.
NATURE GENETICS (2011)
Expanded GGGGCC Hexanucleotide Repeat in Noncoding Region of C9ORF72 Causes Chromosome 9p-Linked FTD and ALS
Mariely DeJesus-Hernandez et al.
NEURON (2011)
Distinct neuroanatomical substrates and cognitive mechanisms of figure copy performance in Alzheimer's disease and behavioral variant frontotemporal dementia
Katherine L. Possin et al.
NEUROPSYCHOLOGIA (2011)
Development of methodology for conducting clinical trials in frontotemporal lobar degeneration
David S. Knopman et al.
BRAIN (2008)
CSF neurofilament proteins in the differential diagnosis of dementia
D. de Jong et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2007)
A tensor based morphometry study of longitudinal gray matter contraction in FTD
Simona M. Brambati et al.
NEUROIMAGE (2007)
CSF neurofilaments in frontotemporal dementia compared with early onset Alzheimer's disease and controls
Yolande A. L. Pijnenburg et al.
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS (2007)
Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17
Matt Baker et al.
NATURE (2006)
Cytoskeleton proteins in CSF distinguish frontotemporal dementia from AD
M Sjögren et al.
NEUROLOGY (2000)